Your email has been successfully added to our mailing list.

×
0.0154320987654321 0.00370370370370384 0.0342592592592595 0 -0.00277777777777766 -0.0108024691358023 0.00709876543209889 -0.00987654320987655
Stock impact report

Tarsus Pharma prices IPO at $a6 [Seeking Alpha]

Tarsus Pharmaceuticals, Inc. (TARS)  More Company Research Source: Seeking Alpha
PDF Tarsus Pharmaceuticals (TARSpricedIn aS-1 filingUnderwriters' over-allotment is an additional 825K shares.Trading kicks off October 16.BofA Securities, Jefferies and Raymond James are acting as joint book-running managers. LifeSci Capital and Ladenburg Thalmann are co-managers.Closing date is October 20.The following pipeline chart presents Tarsus' wholly-owned product candidates and clinical development status:Previously:Tarsus Pharmaceuticals readies $86M IPO [Read more]
Impact snapshot Event time: TARS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
TARS alerts
from News Quantified
Opt-in for
TARS alerts

from News Quantified
Opt-in for
TARS alerts

from News Quantified